PDL1 CPS < 5
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| CAPOX + Bevacizumab + Tislelizumab Treating PD-L1 CPS < 5 Locally Advanced or Metastatic GEA (NCT05299476) | Chinese PLA General Hospital | 2022-04-25 |
Track PDL1 CPS < 5 automatically
Every clearance here is in the API, with alerts when new ones post.